FindTrial
Sign In

Treatment of receeding gums

To evaluate the clinical efficacy of autologous gingival fibroblasts seeded collagen membrane in the management of Millers Class I/II Gingival recession

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/013697
Enrollment
10
Registered
2018-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Gingival recession - Millers Class I/II Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Collagen membrane: Autologous gingival fibroblasts seeded collagen membrane of 20mm length and 15mm width placed into the oral cavity by surgical procedure for a duration of 6 months to

Sponsors

Dr R P Meenakshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Systemically healthy - Millerâ??s Class I/II gingival recession in Maxillary canines/premolars - Thick gingival biotype (2mm) - Adequate keratinized tissue width (2mm) - If cervical enamel defect is present depth - Gingival & Plaque scores

Exclusion criteria

Exclusion criteria: - History of use of antibiotics or anti-inflammatory agents in the last 6 months - History of periodontal treatment in the past 6 months - Acute gingival lesions - Pregnant or lactating women - Smokers or alcoholics

Design outcomes

Primary

MeasureTime frame
Complete Root CoverageTimepoint: 3, 6 and 12 months postoperatively—

Secondary

MeasureTime frame
Clinical Attachment Level gain Recession Depth and Recession Width reduction Increase in Keratinised tissue width Increase in thickness of gingival biotypeTimepoint: 3, 6 and 12 months—

Countries

India

Contacts

Public ContactDr R P Meenakshi
drsivaramg@gmail.com9884013601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026